Evidence map›Paper›PMID 28538169›Full record

ArticleCancer epidemiology2017

Racial differences in colorectal cancer survival at a safety net hospital.

Umit Tapan, Shin Yin Lee, Janice Weinberg, Vijaya B Kolachalama, Jean Francis, Marjory Charlot, Kevan Hartshorn, Vipul Chitalia

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Observational
  10. Serum cytokine profile as a potential prognostic tool in colorectal cancer patients - one center study.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Umit TapanHematology-Oncology Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Shin Yin LeeHematology-Oncology Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Janice WeinbergDepartment of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA.
Vijaya B KolachalamaDepartment of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Jean FrancisDepartment of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Marjory CharlotHematology-Oncology Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Kevan HartshornHematology-Oncology Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Vipul ChitaliaDepartment of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: vichital@bu.edu.
Boston University · US

Funding

Role of c-Cbl in Colon cancerR01CA175382 · NCI · BOSTON MEDICAL CENTER · PI CHITALIA, VIPUL C · 2014 to 2018
$1.8M
NCI NIH HHS R01 CA175382
6 · The paper itself

Abstract

backgroundWhile racial disparity in colorectal cancer survival have previously been studied, whether this disparity exists in patients with metastatic colorectal cancer receiving care at safety net hospitals (and therefore of similar socioeconomic status) is poorly understood.

methodsWe examined racial differences in survival in a cohort of patients with stage IV colorectal cancer treated at the largest safety net hospital in the New England region, which serves a population with a majority (65%) of non-Caucasian patients. Data was extracted from the hospital's electronic medical record. Survival differences among different racial and ethnic groups were examined graphically using Kaplan-Meier analysis. A univariate cox proportional hazards model and a multivariable adjusted model were generated.

resultsBlack patients had significantly lower overall survival compared to White patients, with median overall survival of 1.9 years and 2.5 years respectively. In a multivariate analysis, Black race posed a significant hazard (HR 1.70, CI 1.01-2.90, p=0.0467) for death. Though response to therapy emerged as a strong predictor of survival (HR=0.4, CI=0.2-0.7, p=0.0021), it was comparable between Blacks and Whites.

conclusionsDespite presumed equal access to healthcare and socioeconomic status within a safety-net hospital system, our results reinforce findings from previous studies showing lower colorectal cancer survival in Black patients, and also point to the importance of investigating other factors such as genetic and pathologic differences.

Indexed as

Health Status DisparitiesAdultAgedBlack or African AmericanCohort StudiesColorectal NeoplasmsFemaleHumansKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisNeoplasm StagingProportional Hazards ModelsSafety-net ProvidersSocial ClassAfrican AmericanBlacksColorectal cancerRacial disparitySurvival

Identifiers

PMID28538169
PMCPMC5656256
OpenAlexW2614183748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.